BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17936067)

  • 1. Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality.
    Remme WJ
    Eur J Heart Fail; 2007 Dec; 9(12):1143-5. PubMed ID: 17936067
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
    de Groote P; Isnard R; Assyag P; Clerson P; Ducardonnet A; Galinier M; Jondeau G; Leurs I; Thébaut JF; Komajda M
    Eur J Heart Fail; 2007 Dec; 9(12):1205-11. PubMed ID: 18023249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conclusions on the management of heart failure.
    Swedberg K
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K; Nishii N; Ohe T
    Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination therapy with ARB for heart failure].
    Sakata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
    [No Abstract]   [Full Text] [Related]  

  • 9. [The defibrillator is not a comprehensive healing method].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Aug; 148(31-32):14. PubMed ID: 16938917
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT; Greenberg BH; Yancy CW
    Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to guidelines for patients hospitalized with heart failure: a nationwide survey.
    Jotkowitz AB; Porath A; Shotan A; Mittelman M; Grossman E; Zimlichman R; Lewis BS; Caspi A; Gottlieb S; Garty M;
    Isr Med Assoc J; 2006 Dec; 8(12):875-9. PubMed ID: 17214110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
    Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
    Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing guidelines for heart failure.
    Drexler H; Wollert KC
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S28-33. PubMed ID: 15526240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
    Matthews JC; Johnson ML; Koelling TM
    Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological treatment of chronic heart failure in patients with renal failure].
    Stawicki S; Starczewska MH; Roik M; Opolski G
    Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
    [No Abstract]   [Full Text] [Related]  

  • 20. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.